Medical countermeasures for viral threats with pandemic potential

Section 319L of the Public Health Service Act (42 U.S.C. 247d–7e) is amended— (1) in subsection (c)— (A) in paragraph (4)— (i) in subparagraph (D)— (I) in clause (ii), by striking; and and inserting a semicolon; and (II) by redesignating clause (iii) as clause (iv); and (III) by inserting after clause (ii) the following: (iii) research and development of medical countermeasures for priority virus families that have significant potential to cause a pandemic, including such countermeasures that take either pathogen-specific or pathogen-agnostic approaches, and platform technologies to improve the development and manufacture of such medical countermeasures; and; and (ii) in subparagraph (F)(ii), by inserting or priority virus families and other viral pathogens that pose a threat due to their significant potential to cause a pandemic, after pandemic influenza,; and (B) in paragraph (5), by adding at the end the following: (I) Notification In awarding contracts, grants, cooperative agreements, or other transactions under this section, the Secretary shall communicate to relevant vendors regarding modifications, renewals, extensions, or terminations of contracts, including through the development of a contract notification process, within 30 days of such determination, as practicable.; (2) in subsection (d)(2), by striking $611,700,000 for each of fiscal years 2019 through 2023 and inserting $950,000,000 for each of fiscal years 2025 and 2026; and (3) in subsection (e)(1), by amending subparagraph (D) to read as follows: (D) Sunset This paragraph shall cease to have force or effect after December 31, 2026..